Atria Investments’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.1M Buy
139,632
+13,421
+11% +$1.29M 0.14% 155
2025
Q4
$12.1M Buy
126,211
+3,805
+3% +$370K 0.14% 147
2025
Q3
$11.7M Buy
122,406
+3,579
+3% +$329K 0.13% 159
2025
Q2
$10.4M Buy
118,827
+4,834
+4% +$410K 0.12% 184
2025
Q1
$10.2M Sell
113,993
-705
-0.6% -$63.1K 0.13% 180
2024
Q4
$9.16M Sell
114,698
-6,265
-5% -$542K 0.11% 203
2024
Q3
$10.9M Sell
120,963
-911
-0.7% -$76.6K 0.14% 168
2024
Q2
$9.59M Sell
121,874
-3,657
-3% -$300K 0.12% 179
2024
Q1
$10.9M Sell
125,531
-2,957
-2% -$252K 0.15% 156
2023
Q4
$10.6M Sell
128,488
-208
-0.2% -$15.9K 0.16% 146
2023
Q3
$10.1M Buy
128,696
+2,508
+2% +$210K 0.18% 128
2023
Q2
$11.1M Buy
126,188
+6,554
+5% +$564K 0.2% 107
2023
Q1
$9.65M Buy
119,634
+18,672
+18% +$1.52M 0.18% 134
2022
Q4
$7.85M Sell
100,962
-7,053
-7% -$572K 0.16% 160
2022
Q3
$8.72M Buy
108,015
+9,572
+10% +$860K 0.19% 123
2022
Q2
$8.84M Sell
98,443
-20,702
-17% -$2.1M 0.19% 128
2022
Q1
$13.2M Buy
119,145
+19,380
+19% +$2.05M 0.23% 93
2021
Q4
$10.3M Sell
99,765
-6,738
-6% -$780K 0.18% 131
2021
Q3
$13.3M Buy
106,503
+10,201
+11% +$1.32M 0.24% 90
2021
Q2
$12M Sell
96,302
-3,501
-4% -$440K 0.23% 100
2021
Q1
$11.8M Sell
99,803
-11,622
-10% -$1.36M 0.26% 84
2020
Q4
$13.1M Buy
111,425
+17,306
+18% +$1.91M 0.32% 69
2020
Q3
$9.78M Sell
94,119
-7,105
-7% -$714K 0.3% 78
2020
Q2
$9.28M Sell
101,224
-507
-0.5% -$48.6K 0.32% 75
2020
Q1
$9.17M Buy
101,731
+18,892
+23% +$2.01M 0.7% 30
2019
Q4
$9.4M Buy
82,839
+35,867
+76% +$3.94M 0.25% 86
2019
Q3
$5.1M Buy
46,972
+13,539
+40% +$1.41M 0.18% 110
2019
Q2
$3.4M Buy
33,433
+5,943
+22% +$543K 0.13% 151
2019
Q1
$2.5M Sell
27,490
-1,058
-4% -$94.7K 0.11% 187
2018
Q4
$2.6M Buy
28,548
+3,160
+12% +$295K 0.12% 146
2018
Q3
$2.5M Buy
25,388
+9,690
+62% +$896K 0.1% 185
2018
Q2
$1.34M Buy
15,698
+1,723
+12% +$144K 0.06% 316
2018
Q1
$1.12M Buy
13,975
+811
+6% +$66.9K 0.05% 330
2017
Q4
$1.06M Buy
13,164
+2,615
+25% +$209K 0.05% 326
2017
Q3
$820K Buy
10,549
+540
+5% +$44.8K 0.04% 360
2017
Q2
$888K Buy
10,009
+776
+8% +$65.4K 0.05% 314
2017
Q1
$744K Buy
9,233
+2,591
+39% +$202K 0.05% 309
2016
Q4
$473K Sell
6,642
-3,057
-32% -$240K 0.04% 354
2016
Q3
$838K Buy
9,699
+1,382
+17% +$120K 0.08% 227
2016
Q2
$728K Buy
8,317
+895
+12% +$72.4K 0.08% 197
2016
Q1
$557K Sell
7,422
-1,144
-13% -$86.2K 0.06% 223
2015
Q4
$632K Buy
8,566
+2,620
+44% +$197K 0.07% 194
2015
Q3
$398K Buy
5,946
+903
+18% +$66.5K 0.06% 223
2015
Q2
$374K Sell
5,043
-23
-0.5% -$1.76K 0.04% 286
2015
Q1
$395K Buy
5,066
+598
+13% +$45.3K 0.04% 277
2014
Q4
$323K Buy
4,468
+289
+7% +$20.1K 0.03% 315
2014
Q3
$259K Buy
+4,179
New +$266K 0.03% 399

Other funds holding MDT

Atria Investments's MDT Position: Q1 2026 in Review

Atria Investments increased its Medtronic (MDT) stake by 11% in Q1 2026, buying an estimated $1.29M and bringing the position to 139,632 shares worth $12.1M. The position accounts for 0.14% of the portfolio, ranked #155.

Atria Investments first reported a position in MDT in Q3 2014 and has held it in 47 quarters since. The position peaked at $13.3M in Q3 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Atria Investments held 139,632 shares of Medtronic worth $12.1M as of Q1 2026.
  • Atria Investments bought 13,421 Medtronic shares in Q1 2026, an estimated $1.29M.
  • Medtronic made up 0.14% of Atria Investments's portfolio in Q1 2026, its #155 holding.
  • Atria Investments first reported a position in Medtronic in Q3 2014 and has held it in 47 quarters since.
  • Atria Investments's Medtronic position peaked at $13.3M in Q3 2021.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Atria Investments's 13F filing for Q1 2026, filed 5 May 2026.